Cyclic AMP underpins suppression by regulatory T cells

European Journal of Immunology

Volumn 42, Issue 6, 2012, Pages 1375-1384

  Bodor, Josef ^a,b   Bopp, Tobias ^b   Vaeth, Martin ^a   Klein, Matthias ^b   Serfling, Edgar ^a   Hünig, Thomas ^a   Becker, Christian ^b   Schild, Hansjörg ^b   Schmitt, Edgar ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

CD4 + T cells; Costimulatory molecules; Gene regulation; Regulatory T (Treg) cells; Signal transduction

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CYCLIC AMP; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; HUMAN; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD28; ANTIGENS, CD80; CTLA-4 ANTIGEN; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT MODULATOR; FORKHEAD TRANSCRIPTION FACTORS; HOMEOSTASIS; HUMANS; INTERLEUKIN-2; NFATC TRANSCRIPTION FACTORS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 84862143798     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201141578     Document Type: Review

References (73)

1. Sakaguchi, S., Yamaguchi, T., Nomura, T. and Ono, M., Regulatory T cells and immune tolerance. Cell 2008. 133: 775-787.
2. Fontenot, J. D., Dooley, J. L., Farr, A. G. and Rudensky, A. Y., Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 2005. 202: 901-906.
3. Josefowicz, S. Z., Lu, L-F. and Rudensky, A. Y., Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 2012. 30: 531-564.
4. Bodor, J., Spetz, A. L., Strominger, J. L. and Habener, J. F., cAMP inducibility of transcriptional repressor ICER in developing and mature human T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 1996. 93: 3536-3541.
5. + T lymphocytes. J. Immunol. 2002. 169: 6231-6235.
6. Nabavi, N., Freeman, G. J., Gault, A., Godfrey, D., Nadler, L. M. and Glimcher, L. H., Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 1992. 360: 266-268.
7. Tang, Q. and Bluestone, J. A., The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 2008. 9: 239-244.
8. Molina, C. A., Foulkes, N. S., Lalli, E. and Sassone-Corsi, P., Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell 1993. 75: 875-886.
9. Bopp, T., Becker, C., Klein, M., Klein-Hessling, S., Palmetshofer, A., Serfling, E., Heib, V. et al., Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J. Exp. Med. 2007. 204: 1303-1310.
10. + suppressor T cells in vivo. Nat. Immunol. 2002. 3: 33-41.
11. Bodor, J., Bodorova, J. and Gress, R., Suppression of T cell function: a potential role for transcriptional repressor ICER. J. Leukoc. Biol. 2000. 67: 774-779.
12. Bodor, J., Fehervari, Z., Diamond, B. and Sakaguchi, S., ICER/CREM-mediated transcriptional attenuation of IL-2 and its role in suppression by regulatory T cells. Eur. J. Immunol. 2007. 37: 884-895.
13. Bodor, J., Feigenbaum, L., Bodorova, J., Bare, C., Reitz, M. and Gress, R., Suppression of T-cell responsiveness by inducible cAMP early repressor (ICER). J. Leukoc. Biol. 2001 69: 1053-1059.
14. Barton, K., Muthusamy, N., Chanyangam, M., Fischer, C., Clendenin, C. and Leiden, J. M., Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB. Nature 1996. 379: 81-85.
15. + T cell suppressor function. J. Immunol. 2004. 172: 6519-6523.
16. Vignali, D. A., Collison, L. W. and Workman, C. J., How regulatory T cells work. Nat. Rev. Immunol. 2008. 8: 523-532.
17. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998. 188: 287-296.
18. Gavin, M. A., Rasmussen, J. P., Fontenot, J. D., Vasta, V., Manganiello, V. C., Beavo, J. A. and Rudensky, A. Y., Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007. 445: 771-775.
19. Zheng, Y., Josefowicz, S., Chaudhry, A., Peng, X. P., Forbush, K. and Rudensky, A. Y., Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010. 463: 808-812.
20. +CD25 +TREG cells by targeting AC9 mRNA. EMBO Rep. 2009. 10: 180-185.
21. Conche, C., Boulla, G., Trautmann, A. and Randriamampita, C., T cell adhesion primes antigen receptor-induced calcium responses through a transient rise in adenosine 3′, 5′-cyclic monophosphate. Immunity 2009. 30: 33-43.
22. + regulatory T cells. Blood 2009. 114: 1263-1269.
23. Taskén, K., Waking up regulatory T cells. Blood 2009. 114: 1136-1137.
24. Mehlmann, L. M., Saeki, Y., Tanaka, S., Brennan, T. J., Evsikov, A. V., Pendola, F. L., Knowles, B. B. et al., The Gs-linked receptor GPR3 maintains meiotic arrest in mammalian oocytes. Science 2004. 306: 1947-1950.
25. - T cells leads to the induction of Foxp3 +regulatory T cells in vivo. J. Immunol. 2006. 177: 209-215.
26. Kim, H. P. and Leonard, W. J., CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J. Exp. Med. 2007. 204: 1543-1551.
27. Hori, S., Nomura, T. and Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 2003. 299: 1057-1061.
28. Vaeth, M., Gogishvili, T., Bopp, T., Klein, M., Berberich-Siebelt, F., Gattenloehner, S., Avots, A. et al., Regulatory T cells facilitate the nuclear accumulation of inducible cAMP early repressor (ICER) and suppress nuclear factor of activated T cell c1 (NFATc1). Proc. Natl. Acad. Sci. U.S.A. 2011. 108: 2480-2485.
29. Zheng, Y., Josefowicz, S. Z., Kas, A., Chu, T.-T., Gavin, M. A. and Rudensky, A. Y., Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007. 445: 936-940.
30. Marson, A., Kretschmer, K., Frampton, G. M., Jacobsen, E. S., Polansky, J. K., MacIsaac, K. D., Levine, S. S. et al., Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007. 445: 931-935.
31. Sojka, D. K., Huang, Y.-H. and Fowell, D. J., Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target. Immunology 2008. 124: 13-22.
32. Cardone, J., Le Friec, G., Vantourout, P., Roberts, A., Fuchs, A., Jackson, I., Suddason, T. et al., Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat. Immunol. 2010. 9: 862-871.
33. Bodor, J., Feigenbaum, L., Bodorova, J., Bare, C., Reitz, M. S. and Gress, R. E., Suppression of T cell-responsiveness by inducible cAMP early repressor (ICER). J. Leukoc. Biol. 2001. 69: 1053-1059.
34. Lahl, K., Mayer, C. T., Bopp, T., Huehn, J., Loddenkemper, C., Eberl, G., Wirnsberger, G. et al., Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice. J. Immunol. 2009. 183: 5662-5672.
35. Lahl, K., Loddenkemper, C., Drouin, C., Freyer, J., Arnason, J., Eberl, G., Hamann, A. et al., Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 2007. 204: 57-63.
36. Gogishvili, T., Langenhorst, D., Lühder, F., Elias, F., Elflein, K., Dennehy, K. M., Gold, R. et al., Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice. PLoS One 2009. 4: e4643.
37. Yehia, G., Schlotter, F., Razavi, R., Alessandrini, A. and Molina, C. A., Mitogen-activated protein kinase phosphorylates and targets inducible cAMP early repressor to ubiquitin-mediated destruction. J. Biol. Chem. 2001. 276: 35272-35279.
38. Memin, E., Genzale, M., Crow, M. and Molina, C. A. Evidence that phosphorylation by the mitotic kinase Cdk1 promotes ICER monoubiquitination and nuclear delocalization. Exp. Cell. Res. 2011. 317: 2490-2502.
39. Abrahamsen, H., Baillie, G., Ngai, J., Vang, T., Nika, K., Ruppelt, A., Mustelin, T. et al., TCR-and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling 1. J. Immunol. 2004. 173: 4847-4858.
40. Klein, M., Vaeth, M., Scheel, T., Grabbe, S., Baumgrass, R., Berberich-Siebelt, F., Bopp, T. et al., Repression of cyclic adenosine monophosphate upregulation disarms and expands human regulatory T cells. J. Immunol. 2012. 188: 1091-1097.
41. - helper T cells. J. Leukoc. Biol. 2008. 83: 708-717.
42. Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L. et al., FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006. 126: 375-387.
43. Hogan, P. G., Chen, L., Nardone, J. and Rao, A., Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003. 17: 2205-2232.
44. Bodor, J. and Habener, J. F., Role of transcriptional repressor ICER in cyclic AMP-mediated attenuation of cytokine gene expression in human thymocytes. J. Biol. Chem. 1998. 273: 9544-9551.
45. + regulatory T cells. J. Exp. Med. 2005. 201: 181-187.
46. Kyttaris, V. C., Juang, Y.-T., Tenbrock, K., Weinstein, A. and Tsokos, G. C., Cyclic adenosine 5′-monophosphate response element modulator is responsible for the decreased expression of c-fos and activator protein-1 binding in T cells from patients with systemic lupus erythematosus. J. Immunol. 2004. 173: 3557-3563.
47. Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T. et al., CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008. 322: 271-275.
48. Read, S., Malmstrom, V. and Powrie, F., Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 2000. 192: 295-302.
49. Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W. et al., Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 2000. 192: 303-310.
50. Peggs, K. S., Quezada, S. A., Chambers, C. A., Korman, A. J. and Allison, J. P., Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies. J. Exp. Med. 2009. 206: 1717-1725.
51. Paust, S., Lu, L., McCarty, N. and Cantor, H., Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc. Natl. Acad. Sci. U.S.A. 2004. 101: 10398-10403.
52. Paust, S. and Cantor, H., Regulatory T cells and autoimmune disease. Immunol. Rev. 2005. 204: 195-207.
53. Tang, Q., Adams, J. Y., Tooley, A. J., Bi, M., Fife, B. T., Serra, P., Santamaria, P. et al., Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 2006. 7: 83-92.
54. Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L. et al., Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 2003. 4: 1206-1212.
55. Fassbender, M., Gerlitzki, B., Ullrich, N., Lupp, C., Klein, M., Radsak, M. P., Schmitt, E. et al., Cyclic adenosine monophosphate and IL-10 coordinately contribute to nTreg cell-mediated suppression of dendritic cell activation. Cell Immunol. 2010. 265: 91-96.
56. Ahlmann, M., Varga, G., Sturm, K., Lippe, R., Benedyk, K., Viemann, D., Scholzen, T. et al., The cyclic AMP response element modulator [1] suppresses CD86 expression and APC function. J. Immunol. 2009. 182: 4167-4174.
57. Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J. et al., Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 2011. 332: 600-603.
58. Mendoza-Naranjo, A., Bouma, G., Pereda, C., Ramirez, M., Webb, K. F., Tittarelli, A., Lopez, M. N. et al. Functional gap junctions accumulate at the immunological synapse and contribute to T cell activation. J. Immunol. 2011. 187: 3121-3132.
59. Bour-Jordan, H. and Bluestone, J. A., Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunol. Rev. 2009. 229: 41-66.
60. Tai, X., Cowan, M., Feigenbaum, L. and Singer, A., CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 2005. 6: 152-162.
61. Malek, T. R. and Bayer, A. L., Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 2004. 4: 665-674.
62. Beyersdorf, N., Gaupp, S., Balbach, K., Schmidt, J., Toyka, K. V., Lin, C.-H., Hanke, T. et al., Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. J. Exp. Med. 2005. 202: 445-455.
63. Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D. and Panoskaltsis, N., Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Eng. J. Med. 2006. 355: 1018-1028.
64. Hanke, T., Lessons from TGN1412. Lancet 2006. 368: 1569-1570; author reply 1570.
65. Eastwood, D., Findlay, L., Poole, S., Bird, C., Wadhwa, M., Moore, M., Burns, C. et al., Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells. Br. J. Pharmacol. 2010. 161: 512-526.
66. Bopp, T., Dehzad, N., Reuter, S., Klein, M., Ullrich, N., Stassen, M., Schild, H. et al., Inhibition of cAMP degradation improves regulatory T cell-mediated suppression. J. Immunol. 2009. 182: 4017-4024.
67. Komanduri, K. V. andChamplin, R. E., Can Treg therapy prevent GVHD? Blood 2011. 117: 751-752.
68. Sitkovsky, M. and Lukashev, D., Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat. Rev. Immunol. 2005. 5: 712-721.
69. Caldwell, C. C., Kojima, H., Lukashev, D., Armstrong, J., Farber, M., Apasov, S. G. and Sitkovsky, M. V., Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J. Immunol. 2001. 167: 6140-6149.
70. Sitkovsky, M. V., T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response. Trends Immunol. 2009. 30: 102-108.
71. Kobie, J. J., Shah, P. R., Yang, L., Rebhahn, J. A., Fowell, D. J. and Mosmann, T. R., T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. J. Immunol. 2006. 177: 6780-6786.
72. Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J. F. et al., Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 2007. 204: 1257-1265.
73. Kuczma, M., Lee, J. R. and Kraj, P., Connexin 43 signaling enhances the generation of Foxp3+ regulatory T cells. J. Immunol. 2011. 187: 248-257.